A trial evaluating effect of pramlintide as adjunctive therapy on closed-loop insulin delivery in childrens with type-1-diabetes-mellitus

Trial Profile

A trial evaluating effect of pramlintide as adjunctive therapy on closed-loop insulin delivery in childrens with type-1-diabetes-mellitus

Completed
Phase of Trial: Phase IV

Latest Information Update: 08 Jun 2016

At a glance

  • Drugs Pramlintide (Primary)
  • Indications Type 1 diabetes mellitus
  • Focus Pharmacokinetics
  • Most Recent Events

    • 08 Jun 2016 New trial record
    • 05 May 2016 Primary endpoint has been met. (Change in meal-stimulated plasma glucose excursions), as per an article published in the Diabetes Care
    • 05 May 2016 Results of this and other trial (see profile 233245) published in the Diabetes Care
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top